Differences Between GH- and PRL-Cosecreting and GH-Secreting Pituitary Adenomas: a Series of 604 Cases
The Journal of Clinical Endocrinology & Metabolism · 18.11.2024 · 109 (12) · e2178-e2187
DOI: 10.1210/clinem/dgae126 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, online erschienen am 04.03.2024. Verfasst von Marta Araujo-Castro und 46 weiteren Autor:innen. Beteiligte Einrichtung: Endocrinology & Nutrition Department, Hospital Universitario Ramón y Cajal, 28034 Madrid, Spain. Hauptthemen laut MEDLINE: Growth Hormone-Secreting Pituitary Adenoma, Prolactin, Acromegaly, Adenoma. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 25 Literaturangaben. Gefördert von: Sociedad Española de Endocrinología y Nutrición, Impacto de la co-secreción de prolactina en la expresión de marcadores moleculares y en la respuesta al tratamiento con análogos de somatostatina y agonistas d….
Abstract (Originalsprache)
Context
Few data exist about the clinical course of acromegaly, surgical and medical outcomes in patients with GH- and prolactin cosecreting pituitary adenomas (GH&PRL-PAs). Nevertheless, some series described a more aggressive clinic-radiological behavior than in growth hormone–secreting pituitary adenomas (GH-PAs).
Objective
This work aims to evaluate differences in clinical presentation and in surgical outcomes between GH-PAs and GH&PRL-PAs.
Methods
A multicenter retrospective study was conducted of 604 patients with acromegaly who underwent pituitary surgery. Patients were classified into 2 groups according to serum PRL levels at diagnosis and immunohistochemistry (IHC) for PRL: a) GH&PRL-PAs when PRL levels were above the upper limit of normal (ULN) and IHC for GH and PRL was positive or PRL levels were greater than 100 ng/dL and PRL IHC was not available (n = 130) and b) GH-PA patients who did not meet the previously mentioned criteria (n = 474).
Results
GH&PRL-PAs represented 21.5% (n = 130) of patients with acromegaly. The mean age at diagnosis was lower in GH&PRL-PAs than in GH-PAs (P < .001). GH&PRL-PAs were more frequently macroadenomas (90.6% vs 77.4%; P = .001) and tended to be more invasive (33.6% vs 24.7%; P = .057) than GH-PAs. Furthermore, they had presurgical hypopituitarism more frequently (odds ratio 2.8; 95% CI, 1.83-4.38). Insulin-like growth factor ULN levels at diagnosis were lower in patients with GH&PRL-PAs (median 2.4 [interquartile range (IQR) 1.73-3.29] vs 2.7 [IQR 1.91-3.67]; P = .023). There were no differences in the immediate (41.1% vs 43.3%; P = .659) or long-term postsurgical acromegaly biochemical cure rate (53.5% vs 53.1%; P = .936) between groups. However, there was a higher incidence of permanent arginine-vasopressin deficiency (AVP-D) (7.3% vs 2.4%; P = .011) in GH&PRL-PA patients.
Conclusion
GH&PRL-PAs are responsible for 20% of acromegaly cases. These tumors are more invasive, larger, and cause hypopituitarism more frequently than GH-PAs and are diagnosed at an earlier age. The biochemical cure rate is similar between both groups, but patients with GH&PRL-PAs tend to develop permanent postsurgical AVP-D more frequently.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Endocrinology & Nutrition Department, Hospital Universitario Ramón y Cajal, 28034 Madrid, Spain.
- Endocrinology & Nutrition Department, Hospital Universitario Vall de Hebrón, 08035 Barcelona, Spain.
- Endocrinology & Nutrition Department, Hospital Universitario Central de Asturias, 33011 Asturias, Spain.
- Endocrinology and Nutrition Department, Hospital Universitario de Coruña, 15006 Coruña, Spain.
- Neurosurgery Department, Hospital Universitario Ramón y Cajal, 28034 Madrid, Spain.
- Endocrinology and Nutrition Department, Hospital Universitario de Bellvitge, 08907 Cataluña L'Hospitalet de Llobregat, Spain.
ORCID-Profile: Marta Araujo-Castro, Betina Biagetti, Pablo Abellán Galiana
Förderung
- Sociedad Española de Endocrinología y Nutrición
- Impacto de la co-secreción de prolactina en la expresión de marcadores moleculares y en la respuesta al tratamiento con análogos de somatostatina y agonistas d…
Zitieren
APA
Araujo-Castro, M., Biagetti, B., Menéndez Torre, E., Novoa-Testa, I., Cordido, F., Pascual Corrales, E., Rodríguez Berrocal, V., Guerrero-Pérez, F., Vicente, A., Percovich, J. C., García Centeno, R., González, L., Ollero García, M. D., Irigaray Echarri, A., Moure Rodríguez, M. D., Novo-Rodríguez, C., Calatayud, M., Villar, R., Bernabéu, I., …, & Puig-Domingo, M. (2024). Differences Between GH- and PRL-Cosecreting and GH-Secreting Pituitary Adenomas: a Series of 604 Cases. The Journal of Clinical Endocrinology & Metabolism, 109(12), e2178-e2187. https://doi.org/10.1210/clinem/dgae126
Vancouver
Araujo-Castro M, Biagetti B, Menéndez Torre E, Novoa-Testa I, Cordido F, Pascual Corrales E, et al. Differences Between GH- and PRL-Cosecreting and GH-Secreting Pituitary Adenomas: a Series of 604 Cases. The Journal of Clinical Endocrinology & Metabolism. 2024;109(12):e2178-e2187. doi:10.1210/clinem/dgae126
BibTeX
@article{AraujoCastro2024,
author = {Araujo-Castro, Marta and Biagetti, Betina and Menéndez Torre, Edelmiro and Novoa-Testa, Iría and Cordido, Fernando and Pascual Corrales, Eider and Rodríguez Berrocal, Víctor and Guerrero-Pérez, Fernando and Vicente, Almudena and Percovich, Juan Carlos and García Centeno, Rogelio and González, Laura and Ollero García, María Dolores and Irigaray Echarri, Ana and Moure Rodríguez, María Dolores and Novo-Rodríguez, Cristina and Calatayud, María and Villar, Rocío and Bernabéu, Ignacio and Alvarez-Escola, Cristina and Benítez Valderrama, Pamela and Tenorio-Jimenéz, Carmen and Abellán Galiana, Pablo and Venegas Moreno, Eva and González Molero, Inmaculada and Iglesias, Pedro and Blanco, Concepción and Vidal-Ostos De Lara, Fernando and de Miguel, Paz and López Mezquita, Elena and Hanzu, Felicia and Aldecoa, Iban and Lamas, Cristina and Aznar, Silvia and Aulinas, Anna and Calabrese, Anna and Gracia, Paola and Recio-Córdova, José María and Aviles, Mariola and Asensio-Wandosel, Diego and Sampedro, Miguel and Ruz-Caracuel, Ignacio and Camara, Rosa and Paja, Miguel and Fajardo-Montañana, Carmen and Marazuela, Mónica and Puig-Domingo, Manel},
title = {Differences Between GH- and PRL-Cosecreting and GH-Secreting Pituitary Adenomas: a Series of 604 Cases},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2024},
volume = {109},
number = {12},
pages = {e2178--e2187},
doi = {10.1210/clinem/dgae126}
}
EUVIMED